Juvenile rheumatoid arthritis (jra; still disease) 6

General: Onset before age 16 years; greater occurrence o 252d32c f systemic manifestations, monarticular and oligoarticular joint involvement, and iridocyclitis.

Ocular: Hypopyon; band keratopathy; uveitis; cataract; papillitis; glaucoma; macular edema; ocular pain; vitreous cells; synechiae; scleritis; presumed to have an autoimmune etiology; antiocular antibodies, including iris protein antibodies, have been found in the sera of patients.

Clinical: Salmon pink macular rash; arthritis; hepatosplenomegaly; leukocytosis; chronic pain; joint swelling; low-grade fever; anemia; rheumatoid nodules.

Bloom JN, et al. Serum antiocular antibodies in patients with juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 1993; 30:243-248.

Chylack LT Jr, et al. Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol 1975; 79:1026.

Fraunfelder FT. Roy FH. Current Ocular Therapy, 5th ed. Philadelphia: WB Saunders, 2000.

Hunt DW, et al. Iris protein antibodies in serum of patients with juvenile rheumatoid arthritis and uveitis. Int Arch Allergy Immunol 1993; 100:314-318.

Merriam JC, et al. Early-onset pauciarticular juvenile rheumatoid arthritis. Arch Ophthalmol 1983; 101:1094.

Smiley WK. The eye in juvenile rheumatoid arthritis. Trans Ophthalmol Soc UK 1974; 94:817-829.